Cortechs.ai | Custom lesion segmentation in LesionQuant 2.3

Custom lesion segmentation in LesionQuant 2.3

The 2.3 LesionQuant module of NeuroQuant (FDA cleared, CE marked) makes it easy for physicians to configure two specific lesion segmentation parameters to help define lesions during their review and to aid in their assessment of disease activity on MRIs from new and enlarging T2 FLAIR lesions.

User Configured Lesion Segmentation Parameters

  • Minimum Lesion Size:  For LesionQuant, a lesion is defined as a volume greater than 4 mm3, which appears brighter than gray matter and white matter on a 2D or 3D T2 FLAIR image. The default setting for lesion size is 4 mm3. However, users can set this parameter from 4 mm3 to 64 mm3, in order to increase the minimum size of a lesion being reported in the output.
  • Minimum Lesion Separation:  LesionQuant defines separate lesions as 1 mm voxels away from another lesion. The default setting for lesion separation is 3 mm, however, users can set this parameter between 1 and 5 mm. We recommend 2 mm for 3D/3T images and 3 mm for other scanner teslas and images.

Modifying the Lesion Segmentation Parameters
To configure these parameters, LesionQuant users can set their desired lesion segmentation settings for both lesion size and lesion separation in the Site Configuration tab in the user interface.

The selected lesion segmentation settings, for both current and prior scans, will be displayed on the top of the LesionQuant report.

Cortechs.ai | Custom lesion segmentation in LesionQuant 2.3

Want to learn more about LesionQuant?
We recently had a webinar to discuss the new features available in the LesionQuant from our latest software release. We also examined with case studies how the LesionQuant can help physicians quantify brain structure and lesions and as well as help in effectively evaluating disease activity in MS, based on current guidelines and research.

Our LesionQuant white paper provides more information about the accuracy and reproducibility available using LesionQuant for fully automated FLAIR lesion segmentation.

Do you have a technical question or support need?
The Cortechs.ai Support Team is available Monday through Friday from 7 AM to 5 PM PT.  Emailing [email protected] is the easiest and best way to reach the Cortechs.ai Support Team during and after hours. Sending an email directly to a specific team member may result in delayed response time.

More Resources

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.
Scroll to Top